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Objectives: To investigate he in~uence ofmesothelial ceil (MC) seeding on patency and neointimaI formation of small 
diameter ePTEE grafts in a canine model. 
Materials and Methods: MC were isolated from the omentum, cultured, seeded on fibronectin-coated ePTFE grafts 
(4 cm, 4 mm ID), and implanted in the carotid artery of five Beagle dogs. Each dog also received a non-seeded control 
graft. Patency was assessed by palpation immediately after implantation, and non-invasively by magnetic resonance 
angiography (MRA) after 1 week and just prior to sacrifice (4 weeks). IntimaI thickness was quanti~ed on histological 
sections by use of computer-aided morphometry. 
Results: All grafts were patent after implantation. After 1 week, MRA showed the loss of lumen diameter in two seeded 
grafts. After 4 weeks, two seeded grafts were occluded, one seeded graft was severely stenosed, and all others were without 
angiographic lumen reduction. Histology and morphometry confirmed that two seeded grafts were occluded, and 
demonstrated that the other three seeded grafts showed signi~cantty more intima formation (0.22-1.34 ram) than the 
control grafts (<0.08 mm; p<O.01). 
Conclusions: The MC seeding process decreases patency and increases neointimal formation of small diameter ePTFE 
grafts in dogs and does not seem to be useful for reduction of graft thrombogenicity. 
Key Words: Cell seeding; Vascular grafts; Neointimal formation. 
Introduction 
Prosthetic small diameter bypasses perform poorly 
when compared to autologous vein grafts. 1The throm- 
bogenicity of the prosthetic materials is one of the 
reasons that they have failed to live up to their ex- 
pectations. An endothelial cell monolayer on the lu- 
minal surface may lower the thrombogenicity and 
improve long-term patency, since endothelial cells 
form a non-thrombogenic surface and play a primary 
role in the regulation of intravascular coagulation. 2 In 
man, prosthetic grafts never endothelialise spon- 
taneously, except for a small peri-anastomotic regionP 
Confluent endothelium on prosthetic grafts has been 
achieved, however, by seeding endothelial cells prior 
to implantation. This technique has been studied ex- 
tensively during the past years, and has shown fa- 
vourable results in animal models. 4'5 Although some 
successful human experiments have been described, 5'6 
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clinical introduction has lagged behind. One of the 
major problems of human endothelial cell seeding is 
the limited availability of HLA-compatible ndothelial 
cells. 6 Mesothelial cells have been suggested as a pos- 
sible alternative. Mesothelial cells can be harvested 
easily in large quantities from the omentum of the 
graft recipient 7-11 and, like endothelial cells, they have 
anti-coagulant, 12 anti-thrombotic, 13 and fibrinolytic 14 
activity. Furthermore, mesothelial cells also grow in a 
monolayer and express contact inhibition. The aim of 
the present study was to test the hypothesis that MC- 
seeding improves patency and decreases neointimal 
formation of small diameter ePTFE vascular grafts in 
a canine model. 
Methods 
Animal procedures 
Animal experiments were approved by the ethics com- 
mittee of the University of Utrecht. Animal care and 
1078-5884/98/060489 + 06 $12.00/0 © 1998 W.B. Saunders Company Ltd. 
490 H. J .M.  Verhagen et al. 
handling conformed to the "Position of the American 
Heart Association on Research Animal Use". Five 
conditioned adult Beagle dogs, weighing 10.8-12.8 kg, 
were used for graft implantation, and were housed in 
an animal laboratory with alternating light and dark 
cycles throughout he experiment. All surgical pro- 
cedures were carried out under general anaesthesia. As
premedication, a combination of methadone (10 rag), 
acepromazine (10 mg), and atropine (0.5 rag) were ad- 
ministered intravenously. Subsequently, anaesthesia 
was induced with thiopental (250 mg i.v.) and main- 
tained by mechanical ventilation with a combination 
of oxygen and nitrous oxide (1:2) with 1% halothane. 
During anaesthesia, E.K.G., temperature, and exhaled 
percentage CO2 were monitored. Pain medication (bu- 
prenorfine 0.1 mg) 'was administered by subcutaneous 
injection for 3 days, postoperatively. 
Isolation and culture of mesotheliaI cells 
Under sterile conditions, about half of the omentum 
was excised through a minilaparotomy. A small piece 
was fixed in 4% buffered formaldehyde for histological 
examination, and the rest was placed immediately 
in Medium 199 containing penicillin (100 units/ml), 
streptomycin (100 gg/ml), and amphotericin B (4 gg/ 
ml) (Gibco Europe Ltd, Paisley, U.K.; M199). After 
achieving haemostasis, the wound was closed in two 
layers with absorbable sutures (vicryl 2-0), and the 
animal was allowed to recover. Isolation of mesothelial 
cells was done as described previously. 8 In brief, the 
pieces of omentum were washed with phosphate buf- 
fered saline (PBS), cut in four equal pieces, and trans- 
ferred to pre-warmed PBS containing 0.05% trypsin- 
0.02% EDTA (Gibco). After 15 min incubation at 37 °C 
under gentle shaking, the detached mesothelial cells 
were pelleted by centrifugation at1200 rpm for 10 min. 
The pelleted cells were resuspended in 48 ml of M199 
containing 20% Foetal Calf Serum (Gibco; FCS), and 
cultured in four polystyrene flasks (Costar, Cambridge, 
MA, U.S.A.; 75 cm 2 each), which had been precoated 
with fibronectin. Cells were grown in a fully hu- 
midified 5% CO2 incubator at 37 °C. Culture medium 
was routinely changed every other day, and after about 
5 days a confluent monolayer of mesothelial cells 
was formed. Their identity was confirmed by dem- 
onstrating the presence of intracellular cytokeratins 
using a monoclonal antibody (Dako, Glostrup, Den- 
mark; MNF116; ~-Ck) ,  9'~5 and by the absence of staining 
with a polyclonal antibody against human von Wil- 
lebrand factor (Sigma, ~-VWF). 
Fig. 1. Seeding chamber used forseeding the complete luminal 
surface of the vascular prostheses. A piece of prosthesis (8 cm; 4 mm 
I.D.) is immobilised between two stainless teel cannulas, and 
sterilised before use. 
Cell seeding 
On the day before graft implantation (after 6 days of 
culture), the cells were rinsed with HEPES buffered 
saline (10 mM HEPES, 145 mM NaC1, pH 7.4; HBS) and 
harvested by trypsin treatment. The number of cells 
was determined by fluorometric measurement of the 
DNA content of aliquots from harvested cells, com- 
plexed with Hoechst dye (33258; Boehringer Mann- 
heim; Germany). Cell numbers were derived from a 
standard curve relating quantities of DNA in MC 
suspensions with known quantities of a calf thymus 
DNA (Sigma) standard. 16'17 All cells were resuspended 
in 12 ml of culture medium. Cell viability was de- 
termined by Trypan Blue dye exclusion and always 
exceeded 95%. 
For seeding the complete luminal surface of the 
vascular prostheses, we used a seeding chamber as 
described before. 18 In brief, a standard ePTFE pros- 
thesis (8 cm long, 4 mm I.D.; supplied by W.L. Gore & 
Assoc., Flagstaff, Arizona, U.S.A.) was immobilised 
between two stainless steel cannulas inside a po- 
lymethylpentene tube (Fig. 1). The total volume of the 
prosthesis and cannulas measured 3.0 ml, the cannulas 
could be moved within the seeding chamber and 
locked in place. With the prosthesis in situ, the seeding 
chamber was sterilised. Fibronectin was purified from 
Beagle plasma in the same way as described for puri- 
fication of human fibronectin, 19and was used to pre- 
coat the graft for I h at 37 °C (100 ~tg/ml = 15 ~tg/cm2). 
After rinsing the prosthesis with HBS, the first 3.0 ml 
of the seeding suspension were introduced and the 
prosthesis was placed horizontally in the incubator. 
After 30 min, the culture medium with the unattached 
cells were removed, and another 3.0ml was in- 
troduced. The prosthesis was placed again horizontally 
in an incubator, otated at a 90 ° angle from its previous 
position. This seeding procedure was repeated twice, 
in which the vascular prosthesis was rotated com- 
pletely (2 h), so that all sides were seeded with cells. 
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Subsequently, the prosthesis was kept horizontally in 
the incubator overnight (,-~20 h) for implantation the 
next day. 
Graft implantation 
Each dog underwent bilateral replacement of a seg- 
ment of the carotid artery with a seeded graft on one 
side and an unseeded control on the other. During 
induction of anaesthesia,  single dose of antibiotics 
was administered intravenously (amoxicillin 400 mg). 
Both carotid arteries were exposed through a midline 
neck incision, and 100 U/kg of heparin was given 
(Leo Pharmaceutical, Weesp, The Netherlands). A 2 cm 
segment of each of the carotid arteries was removed 
and to match the retraction of the cut ends, a 4 cm 
graft was implanted. First, the non-seeded ePTFE 
control graft was implanted on the right side. The 
autologous eeded graft was used in the left carotid 
artery. When the seeded graft was implanted, it was 
rinsed thoroughly with M199 culture medium (without 
serum), and two I cm pieces were excised and fixed 
for scanning electron microscopic (SEM) evaluation of 
the seeding process. Care was taken to keep the seeded 
prostheses misted during the operation. End-to-end 
anastomoses were made microscopically (mag- 
nification x 10), using 8-0 polypropylene interrupted 
sutures (prolene, Ethicon, Somerville, NJ, USA). Just 
prior to the last suture, the grafts were flushed to 
remove any possible clots. After achieving hae- 
mostasis, the wounds were closed in three layers using 
absorbable sutures (vicryl 2-0), and the animal was 
allowed to recover. All dogs were medicated through- 
out the experiments with oral acetyl salicylic acid 
(ASA, 80 mg once a day), beginning 1 week before 
implantation. 
Assessment ofgraft patency 
Patency of the implanted grafts was assessed in three 
different ways. First, by palpation just prior to closure 
of the wounds. Second, by magnetic resonance angio- 
graphy (MRA), I week and 4 weeks after implantation. 
Third, at the time of sacrifice by incision of the distal 
native artery. MRA was performed at the National In 
Vivo NMR Facility, Utrecht University, The Neth- 
erlands, on a SISCO 200MHz (4.7T) spectrometer 
(Varian, Palo Alto, U.S.A.), equipped with an actively 
shielded gradient coil (maximal gradient strength 
32mT/m and a 29.5cm clear bore). Imaging was 
performed using a saddle type transmit-receive radio- 
frequency coil (inner diameter 16 cm). The dogs were 
anaesthetised asdescribed before, placed in a supine 
position in a cradle, and the target area was positioned 
in the centre of the radiofrequency coil. Routinely, a 
transversal multislice Tl-weighted spin-echo sequence 
was used as a scout to select the slices of interest. 
Multiple positions proximal-to, distal-to, and in the 
centre of the grafts were selected. These positions were 
then imaged with a flow sensitive SSFP sequence. The 
intensity of the occurring flow artifacts gives a good 
qualitative impression of flow present. 
For the multislice Tl-weighted spin-echo sequence 
the following parameters were typically used: re- 
petition time: 2.7 s; echo time 25 ms; 5 ms sinc pulses; 
field-of-view: 15 x 15 cm2; slice thickness: I mm; 
128 x 128 points data matrix in the acquisition, zero- 
filled to 512 x 512 for display and evaluation. The SSFP 
sequence required the following parameters: repetition 
time: 100 ms; echo time 6 ms; 2 ms gauss pulses; field- 
of-view: 15 x 15 cm2; slice thickness: I mm; 128 x 128 
points data matrix in the acquisition, zero-filled to 
512 x 512 for display and evaluation. 
Removal of grafts 
Immediately after the second MRA, 4 weeks after 
implantation of the grafts, the midline neck incision 
was reopened. Heparin (100 U/kg) was administered 
to prevent graft thrombosis during removal. The grafts 
were exposed by careful dissection. The carotid arteries 
were clamped distal to the prostheses and a small 
incision was made just proximal to the clamps as a 
final control of graft patency. Subsequently, clamps 
were placed proximal to the grafts as well and the 
dogs were sacrificed by intravenous administration 
of pentobarbital (3 gram). Each graft was removed 
together with an adjacent segment of the native artery 
at both ends, rinsed with PBS, and fixed for histological 
and scanning electron microscopic examination. 
The abdominal cavity was inspected macro- 
scopically, to see whether emoval of half of the omen- 
turn had any influence on intra-abdominal dhesion 
formation. 
Histopathological examination 
Representative transverse sections of approximately 
0.3 cm from each of the seeded and control grafts were 
fixed in 4% buffered formaldehyde for at least 24 h, 
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and embedded in paraffin. Serial sections of 5gm 
thickness were cut (at intervals of 300 gm) and stained 
with either haematoxylin and eosin (HE), elastic van 
Gieson (EvG), or periodic acid silver methenamin/ 
azophloxin-anilin (PASM/AZAN), and with the anti- 
bodies ~-Ck, ~-VWF, and ~-SMA (smooth muscle actin; 
Sigma). For quantification of neointima (NI), HE- 
stained sections were photographed at x 10 mag- 
nification. The specimens were then analysed mor- 
phometrically using a computerised image analysis 
system (Zeiss Video Plan; Zeiss; Germany). The thick- 
ness of the neointima was measured at four different 
spots within one section, five sections (at intervals of 
300 gm) were measured. All measurements (n = 20) for 
one prosthesis were averaged. 
Each graft prepared for scanning electron micro- 
scopy (SEM) was fixed in 2% glutaraldehyde for i h, 
postfixed in 1% osmium tetroxide (Sigma) for i h, and 
then dehydrated through increasing concentrations of 
ehtanol (50-100%). Samples were critical point dried 
(Balzers Union, Lichtenstein; CPD 010), sputtered with 
gold (Balzers Union, SCD 040), and finally examined 
with a scanning electron microscope (Camscan, Cam- 
bridge, U.K.). 
Fig. 2. Scarming electron micrograph of a seeded graft at the time 
of implantation. A confluent monolayer ofmesothelial cells and 
some rythrocytes can be seen (original magnification x 1000). 
demonstrated that a confluent monolayer of meso- 
thelial cells was present on the luminal surface of the 
grafts at the time of implantation (Fig. 2). 
Statistical analysis 
Results are expressed as mean+standard deviation 
(S.D.). A paired non-parametric test was used to deter- 
mine significant differences (Wilcoxon signed rank 
test). A p value <0.05 was considered significant. 
Results 
Isolation of mesothelial cells 
From every dog, about half of the omentum ( ~ 75 cm2; 
15-20 g) was excised for cell isolation. No growth 
failures were found after cell isolation. At the time of 
sacrifice, no anatomical changes or adhesion formation 
was seen in the abdominal cavity. At the day of seeding 
(6 days after isolation) a mean of 9.5 x 106 (range: 
7.7-11.6 x 10 6) mesothelial cells were harvested and 
resuspended in 12 ml of M199 containing 20% FCS. 
The mean cell density used for seeding the grafts 
was 3.3 x 105 cells/cm 2 (range: 2.7-4.0 x 105). Scanning 
electron microscopic evaluation of the seeding process 
Patency of implanted grafts 
Just prior to closing of the wound after graft im- 
plantation, all grafts were palpated and found to be 
open. One week after implantation, MRA was per- 
formed in four dogs and demonstrated that all eight 
grafts were patent. Two of the seeded grafts, however, 
showed decreased flow and reduction in lumen dia- 
meter on the level of the prosthesis. After 4 weeks, 
MRA was performed on all five dogs. The dog that 
was not available for MRA after 1 week showed a 
complete occlusion of the seeded prosthesis. One of 
the two seeded grafts that had shown a clear lumen 
reduction after 1 week was now occluded, the other 
one showed minimal flow. Two seeded prostheses, and 
all control grafts, were patent without angiographic 
lumen reduction. There had been no neurological 
symptoms despite occlusion or severe stenosis. 
Histopathological examination 
All grafts showed some degree of peripheral tissue 
ingrowth into the prosthetic material. On the luminal 
surface, hardly any tissue was found in the control 
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(a) 
Fig. 3. Representative transverse sections of a control ePTFE graft 
(a) and an MC-seeded ePTFE graft (b), 4 weeks after implantation 
in the carotid artery of a d g.On the luminal side (L) of the control 
graft no neointimal formation was seen. In the seeded graft the 
lumen diameter is clearly reduced by a thick neointimal layer. The 
sections were stained with haematoxylin and eosin (HE). Original 
magnification x 50 (a) and x 25 (b). P = prosthesic graft. 
grafts (Fig. 3a). Two MC seeded grafts showed a 
complete occlusion, and three showed a thick neo- 
intima, which was present hroughout the complete 
graft (Fig. 3b). The thickness of the neointima is ex- 
pressed in Table 1. All the seeded grafts showed 
significantly more intimal tissue than the control grafts 
(p<0.01). Staining the seeded grafts with PASM/ 
AZAN, and with antibodies against SMA, vWF, and 
Ck demonstrated that the neointima consisted largely 
of myofibroblasts and connective tissue matrix. No 
autologous MC could be found. The occluded seeded 
grafts showed an almost completely organised throm- 
bus. The presence of endothelial cells in the mid- 
portion of any of the grafts could not be demonstrated. 
SEM of the luminal surface of the control grafts 
demonstrated a thin rough layer of fibrinous material 
on the ePTFE with erythrocytes, leucocytes, and plate- 
lets attached to it. Pannus ingrowth of an endothelial- 
like non-thrombogenic cellular layer covered all ana- 
stomoses and stopped at a distance of about 5 mm 
from each suture line inside the prostheses (Fig. 4). 
Anastomotic stenoses were not observed. SEM of the 
seeded grafts showed acellular fibrous tissue on the 
surface of the prostheses. All adjacent native carotid 
arteries howed a non-thrombogenic surface with in- 
tact endothelium. 
Discussion 
When prosthetic grafts are implanted into humans, 
the luminal surface becomes covered with platelets, 
blood cells and fibrin. R° In man, prosthetic grafts fail 
to develop an endothelial cell lining spontaneously, 3 
so the surface remains thrombogenic for years and 
contributes to accelerated luminal occlusion. The cre- 
ation of a biological, anti-thrombotic lining on the 
luminal surface of prosthetic grafts may be achieved 
by cell seeding prior to implantation. Endothelial cells 
(EC) are naturally best suited to line blood vessels, 
but it takes weeks to culture enough cells to line a 
complete peripheral bypass and growth failures occur 
in about 25% of the cases. 6 Veins large enough to 
isolate sufficient numbers of cells would obviously be 
the preferred choice of bypass conduit. 1Mesothelial 
cells (MC) could be an alternative for EC since they 
have anti-coagulant, anti-thrombotic and fibrinolytic 
properties, 12-14 and it takes only about 5 days to culture 
enough cells. 7-1° This study was designed to investigate 
in vivo the possibility of using MC for cell seeding 
onto small diameter vascular prostheses. 
By implanting both a seeded and a control graft in 
one dog, we could exclude the known variability in 
haemostatic properties between dogs. The dogs were 
medicated throughout he experiments with ASA 
because in small-calibre grafts in dogs, antiplatelet 
drugs are necessary to keep the control graft from 
clottingY 1 After 4 weeks, the seeded prostheses 
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Table 1. The influence of mesothelial cell seeding on patency and neointimal formation of small diameter prosthetic grafts in a dog 
model. 
Dog MRA Intimal thickness p value 
1 week 4 weeks Mean--S.D. (mm) Seeded vs. standard 
I Seeded ? Occl 2.0 <0.01 
Standard ? NLR <0.08 
II Seeded Stenosis Occl 2.0 <0.01 
Standard NLR NLR <0.08 
III Seeded Stenosis Severe stenosis 1.34 ,, 0.47 <0.01 
Standard NLR NLR <0.08 
IV Seeded NLR NLR 0.83 ± 0.11 <0.01 
Standard NLR NLR <0.08 
V Seeded NLR NLR 0.22 ,, 0.03 <0.01 
Standard NLR NLR <0.08 
Pieces of ePTFE vascular prostheses (4cm length, 4 mm internal diameter) were implanted end-to-end in the carotid position in four dogs. 
A standard prosthesis was placed on the right side, a seeded prosthesis was placed in the left position. After i week, patency was assessed 
by magnetic resonance angiography (MRA) in four dogs. Four weeks after implantation, MRA was performed in all five dogs and the 
prostheses were removed for histological examination. Intimal thickness is stated as mean,,  S.D., based on 20 measurements throughout 
the complete length of the explanted prostheses. The Wilcoxon signed-rank test was used for statistical analysis. 
occl: occluded. 
NLR: no angiographic reduction in lumen diameter. 
Fig. 4. Scanning electron micrograph of the luminal surface of a 
control graft after implantation for 4 weeks. On the right, fibrinous 
material is seen with erythrocytes, leucocytes, and platelets attached 
to it. Pannus ingrowth of a non-thrombogenic endothelial cell layer 
is seen on the left side. (Original magnification x 250). 
showed either occlusion, severe stenosis, or distinct 
lumen reduction, while the control grafts showed 
hardly any decrease in lumen diameter. The ac- 
celerated formation of neointimal tissue may therefore 
be explained by the MC seeding process. Human 
mesothelial cells in culture are known to increase the 
expression of tissue factor, the physiological ctivator 
of coagulation. 9 We have described before that mani- 
pulation of culture conditions decreased the tissue 
factor expression on MC to the same level as that 
measured on cultured adult endothelial cells, 8 and that 
the activity of anticoagulant thrombomodulin was 
significantly higher on MC than on EC. 11 At present, no 
information is available on the haemostatic functions 
of canine MC. In our study, it is obvious that the 
procoagulant properties of mesothelial cells over- 
powered the anticoagulant properties. Whether this is 
due to the absence or low activity of thrombomodulin, 
prostacyclin, itric oxide, or heparan sulphates on dog 
mesothelial cells is unknown. 
After 4 weeks, no MC could be demonstrated histo- 
logically on the seeded grafts. A possibility is that the 
cells were lost during thrombus formation, since high 
concentrations of thrombin and fibrin degradation 
products are present in bloodclots. Both are very strong 
cell activators, leading to dysfunction and detachment 
of seeded cells. 22'23 Another possibility is that the MC 
were washed away from the surface of the prostheses, 
leaving the thrombogenic subcellular matrix. This may 
have happened after some time, because we have 
previously demonstrated that a monolayer of MC, 
present on the graft at the time of implantation, is
resistant o shear stress characteristic for medium- 
sized arteries. 24A third possibility is that the MC 
were still present but could not be recognised by the 
antibody, possibly because specific receptors on MC 
changed ue to alteration of environment. From this 
study, no conclusions could be drawn on the time of 
onset of thrombus formation. We confirmed patency 
of all grafts by palpation after implantation, so acute 
occlusion due to massive activation of the coagulation 
cascade by tissue factor did not occur. On the other 
hand, histology of the seeded grafts howed organised 
tissue, suggesting that the thrombus formation oc- 
curred quite some time before sacrifice. 
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Patency of the carotid grafts was assessed non- 
invasively at 1 and 4 weeks after implantation by 
magnetic resonance angiography (MRA). This rapidly 
developing imaging technique has been applied to 
many regions of the body as and seems to be capable of 
providing anatomic information equivalent to contrast 
ar ter iography  (CA). 26-28 In this study, occlusion or 
severe stenosis was imaged correctly by MRA, but 
the moderately stenosed seeded grafts could not be 
distinguished from the completely open controls. In 
the past we used Doppler ecordings to monitor graft 
patency but that proved to be very unreliable when 
ePTFE grafts were used. Duplex ultrasonography is 
probably the best way to monitor graft patency non- 
invasively in this model. 
Recently, a compilation of the results of nine pub- 
lished trials was described, all using 4 mm inner dia- 
meter synthetic grafts in a paired dog model of 
endothelial cell seeding, a°A positive benefit of EC 
seeding with respect to graft patency was consistently 
observed. Cell seeding studies using omentally de- 
rived cells were also described before, but it is difficult 
to make a comparison with these studies ince there 
are justifiable doubts about the characterisation f the 
cells in those studies. Most of them described the use 
of microvascular endothelial cells isolated from the 
omentum, 29'3° but EC are usually not isolated from 
the omentum. 31 This could mean that MC were used 
instead of EC, making it necessary tore-evaluate hese 
studies before comparisons can be made. Well-char- 
acterised MC have been used for cell seeding pro- 
cedures in animal models, but no significant change 
in thrombogenicity or patency was shown3 ~ Studying 
this work more closely, the results seem predictable. 
A low cell inoculum was used and the cells were 
inadequately attached and spread on the Dacron pros- 
theses, resulting in an almost complete loss of cells, 
as was demonstrated after 48 h. Inadequately attached 
MC, however, are lost within minutes when they are 
subjected to physiological shear forces. 1s'24 
From this study, we may conclude that the process 
of mesothelial cell seeding does not improve patency, 
nor does it decrease neointimal formation, of small 
diameter ePTFE grafts in Beagle dogs. Although 
many MC functions are still unknown, it seems that 
the procoagulant properties of cultured MC were 
more effective than the anticoagulant function. The 
prosthetic material proved to be thrombogenic, but 
ingrowth of a completely anti-thrombogenic endo- 
thelium was observed in all control grafts. This sup- 
ports the original idea of endothelial cell seeding, and 
makes it worth studying other sources for cell seeding 
procedures which may provide anti-thrombogenic 
vascular prostheses. 
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